查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736771

全球生物加工技術市場：按產品、應用、最終用戶、區域範圍和預測

Global Bioprocess Technology Market By Product, By Application, By End User, By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

生物加工技術的市場規模與預測

2024 年生物加工技術市場規模價值 287 億美元，預計到 2032 年將達到 603 億美元，在 2026-2032 年預測期內的複合年成長率為 10.70%。

生物加工技術是指利用活細胞及其成分來開發產品和工藝，以提高生物材料的產量。

該技術對於各種應用都至關重要，包括藥品、酵素、生質燃料和食品的生產，因為它利用生物系統實現效率和永續性。

生物加工技術的未來前景光明，合成生物學、基因組學和自動化領域的進步有望帶來更有效率的生產方法以及個人化醫療、可再生能源和永續農業等領域的創新應用。

生物加工技術的全球市場動態

影響全球生物加工技術市場的關鍵市場動態是：

關鍵市場促進因素

生物製藥需求不斷成長：受慢性病發病率上升和個人化醫療技術進步的推動，生物製藥行業正在快速擴張。根據《2023年全球生物製藥市場報告》，預計2025年，生物製藥市場規模將達到3.8兆美元，複合年成長率為8.6%。

生物技術進步：包括基因編輯和合成生物學在內的生物技術創新正在提高生物過程的效率和生產力。根據美國國立衛生研究院 (NIH) 的報告，2021 年生物技術研發投資將達到約 650 億美元，顯示該領域技術進步的強勁投入。

更重視永續性：各行各業越來越重視永續實踐，尤其是在生質燃料和生物分解性材料的生產領域。根據國際可再生能源機構 (IRENA) 的報告，全球生質燃料市場預計將以 6.5% 的複合年成長率成長，到 2027 年達到 1,850 億美元。

政府支持和資金：世界各國政府正在提供大量資金和獎勵，以支持生物加工技術的發展。例如，美國能源局(DOE) 宣布將在 2023 年投資 5,700 萬美元用於生質能源技術的開發，這反映了政府對生物加工創新的大力支持。

主要問題

監管障礙：生物製程技術領域面臨複雜的監管要求，這會延遲產品核准、增加成本，並需要大量時間和資源來應對。

生產成本高：生物加工技術（包括設備和原料）的初始投資可能很大，導致生產成本高，並可能阻礙中小企業進入市場。

可擴展性問題：從實驗室規模的流程轉向商業規模的生產可能會帶來一些挑戰，例如在擴大規模的過程中保持產品品質和一致性。

人才短缺：生物加工領域對熟練專業人員的需求正在成長，但合格人才的短缺可能會限制產業的創新和發展。

主要趨勢

自動化和人工智慧的整合：自動化和人工智慧在生物加工中的應用日益廣泛，提高了效率，減少了人為錯誤，並實現了流程的即時監控和最佳化。

轉向連續處理：人們正在轉向連續生物處理，這比傳統的批量處理具有優勢，包括更短的生產時間和更高的產品品質。

關注個人化醫療：個人化醫療的興起正在推動生物加工技術的創新，從而發展出適合個別患者需求的治療方法。

永續實踐和綠色技術：根據全球永續性目標，人們擴大採用永續實踐和環保技術，例如使用可再生資源和減少廢棄物。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查時間表
  • 先決條件
  • 限制

第2章調查方法

  • 資料探勘
  • 二次研究
  • 初步研究
  • 專家建議
  • 品質檢查
  • 最終審核
  • 數據三角測量
  • 自下而上的方法
  • 自上而下的方法
  • 調查流程
  • 資料來源
  • 業界專家的重要見解

第3章執行摘要

  • 市場概覽
  • 全球生物加工技術生態系圖譜
  • 全球生物加工技術市場的吸引力
  • 全球生物加工技術絕對商機
  • 全球生物加工技術市場的地理洞察
  • 全球生物加工技術市場（按類型）
  • 全球生物加工技術市場（按應用）
  • 全球生物加工技術市場（按最終用戶分類）
  • 未來市場機會
  • 全球市場區隔

第4章 市場展望

  • 生物程序技術全球市場展望
  • 市場促進因素
    • 疾病負擔加重。
    • 外包生物製程開發趨勢日益成長
  • 市場限制
    • 資金投入高、設備昂貴
    • 嚴格的政府法規。
  • 可能性
    • 增加對生技研發的投資
    • 強大的生物製藥產品線
  • COVID-19對全球市場的影響
  • 波特五力分析
    • 新進入者的威脅
    • 替代品的威脅
    • 供應商的議價能力
    • 買家的議價能力
    • 競爭對手之間的競爭強度
  • 宏觀經濟分析
  • 價值鏈分析

第5章 按產品分類的市場

  • 概述
  • 生物加工設備
  • 生物加工服務

第6章 按應用分類的市場

  • 概述
  • 製藥
  • 生物技術
  • 飲食
  • 環境管理

第7章 終端用戶市場

  • 概述
  • 生物製藥公司
  • 學術和研究機構
  • 受託製造廠商

第8章 區域市場

  • 概述
  • 北美洲
    • 北美市場概述
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲市場概述
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 亞太市場概述
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 拉丁美洲市場概述
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 中東和非洲市場概述
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲地區

第9章 競爭態勢

  • 概述
  • 競爭場景
  • 各公司市場排名分析
  • 區域足跡
  • 公司在各行業的足跡
  • 王牌矩陣
    • 積極的
    • 前線
    • 新興
    • 創新者

第10章 公司簡介

  • GE HEALTHCARE COMPANY
  • THERMO FISHER SCIENTIFIC
  • DANAHER CORPORATION
  • LCG GROUP
  • MERCK GROUP
  • LONZA GROUP AG
  • SARTORIUS AG.
  • CORNING INCORPORATED
  • BIO-RAD LABORATORIES, INC.
Product Code: 40850

Bioprocess Technology Market Size And Forecast

Bioprocess Technology Market size was valued at USD 28.7 Billion in 2024 and is projected to reach USD 60.3 Billion by 2032, growing at a CAGR of 10.70% from 2026 to 2032.

Bioprocess technology refers to the use of living cells or their components to develop products and processes that enhance the production of biological materials.

This technology is pivotal in various applications, including the production of pharmaceuticals, enzymes, biofuels, and food products, as it leverages biological systems for efficiency and sustainability.

The future of bioprocess technology is promising, driven by advancements in synthetic biology, genomics, and automation, which are expected to lead to more efficient production methods and innovative applications in fields such as personalized medicine, renewable energy, and sustainable agriculture.

Global Bioprocess Technology Market Dynamics

The key market dynamics that are shaping the global bioprocess technology market include:

Key Market Drivers:

Growing Demand for Biopharmaceuticals: The biopharmaceutical sector is expanding rapidly, driven by the increasing prevalence of chronic diseases and advancements in personalized medicine. According to the Global Biopharmaceutical Market Report 2023, the market is expected to reach USD 3.8 trillion by 2025, growing at a compound annual growth rate (CAGR) of 8.6%.

Advancements in Biotechnology: Innovations in biotechnology, including gene editing and synthetic biology, are enhancing the efficiency and productivity of bioprocesses. A report from the National Institute of Health (NIH) highlights those investments in biotechnology research and development reached approximately USD 65 billion in 2021, indicating a strong commitment to technological advancements in this field.

Increasing Focus on Sustainability: There is a growing emphasis on sustainable practices in various industries, particularly in the production of biofuels and biodegradable materials. The International Renewable Energy Agency (IRENA) reports that the global biofuels market is projected to grow at a CAGR of 6.5%, reaching USD 185 billion by 2027.

Government Support and Funding: Many governments worldwide are providing substantial funding and incentives to support bioprocess technology development. For instance, the U.S. Department of Energy (DOE) announced an investment of USD 57 million in 2023 to advance bioenergy technologies, reflecting strong governmental backing for bioprocess innovations.

Key Challenges:

Regulatory Hurdles: The bioprocess technology sector faces complex regulatory requirements that can delay product approvals and increase costs. Navigating these regulations requires significant time and resources.

High Production Costs: The initial investment for bioprocess technology, including equipment and raw materials, can be substantial, leading to high production costs that may hinder market entry for smaller companies.

Scalability Issues: Transitioning from laboratory-scale processes to commercial-scale production can pose challenges, including maintaining product quality and consistency during scale-up.

Talent Shortage: There is a growing demand for skilled professionals in bioprocessing, but a shortage of qualified personnel can limit innovation and development within the industry.

Key Trends:

Integration of Automation and AI: The increasing use of automation and artificial intelligence in bioprocessing is enhancing efficiency, reducing human error, and enabling real-time monitoring and optimization of processes.

Shift towards Continuous Processing: There is a trend toward continuous bioprocessing, which offers advantages over traditional batch processing, such as reduced production time and improved product quality.

Focus on Personalized Medicine: The rise of personalized medicine is driving innovation in bioprocess technology, leading to the development of tailored therapies that meet individual patient needs.

Sustainable Practices and Green Technologies: The industry is increasingly adopting sustainable practices and green technologies, such as using renewable resources and minimizing waste, to align with global sustainability goals.

Global Bioprocess Technology Market Regional Analysis

Here is a more detailed regional analysis of the global bioprocess technology market:

North America:

North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The region is home to a large number of biopharmaceutical firms that invest heavily in innovative bioprocessing technologies. According to a report by the Biotechnology Innovation Organization (BIO), the U.S. biopharmaceutical sector generated over $300 billion in revenue in 2023, highlighting the significant economic impact of bioprocess technologies.

Additionally, government initiatives and funding have further supported the growth of the bioprocess technology sector. For instance, the National Institutes of Health (NIH) has allocated approximately $50 billion annually to support biomedical research, including advancements in bioprocessing technologies. This financial backing encourages the development and commercialization of new biopharmaceutical products, reinforcing North America's leadership in the market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology. Countries like China and India are emerging as key players due to their growing biopharmaceutical sectors and expanding manufacturing capabilities. According to a report by the Asian Development Bank (ADB), the biotechnology market in Asia is projected to grow at a CAGR of over 15% from 2024 to 2030, underscoring its rapid expansion.

Additionally, the supportive government policies in countries like China, which includes the "Made in China 2025" initiative aimed at enhancing the biotechnology sector, are propelling market growth. The increasing focus on research and development in bioprocess technologies to meet the rising demand for biologics and biosimilars is further driving this growth trajectory in the Asia Pacific region.

Global Bioprocess Technology Market: Segmentation Analysis

The Global Bioprocess Technology Market is segmented on the basis of Product, Application, End User, and Geography.

Bioprocess Technology Market, By Product

  • Bioprocess Instruments
  • Bioprocess Services

Based on Product, the Global Bioprocess Technology Market is segmented into Bioprocess Instruments and Bioprocess Services. The bioprocess instruments is the dominating segment, driven by the demand for advanced equipment such as bioreactors, fermenters, and analytical tools essential for biopharmaceutical production and research. However, the bioprocess services segment is the fastest growing, fueled by the increasing complexity of bioprocesses and the need for outsourcing specialized services like cell line development, process optimization, and regulatory compliance.

Bioprocess Technology Market, By Application

  • Pharmaceuticals
  • Biotechnology
  • Food and Beverage
  • Environmental Management

Based on Application, the Global Bioprocess Technology Market is segmented into Pharmaceuticals, Biotechnology, Food and Beverage and Environmental Management. The pharmaceuticals is the dominating segment, driven by high demand for biopharmaceuticals and advanced therapies. However, the biotechnology segment is the fastest-growing, propelled by innovations in genetic engineering, personalized medicine, and vaccine development.

Bioprocess Technology Market, By End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Manufacturing Organizations

Based on End User, the Global Bioprocess Technology Market is segmented into Biopharmaceutical Companies, Academic and Research Institutes and Contract Manufacturing Organizations. Biopharmaceutical companies dominate the landscape, as they represent a significant portion of the overall market due to their substantial investments in research and development for drug production. However, the contract manufacturing organizations (CMOs) segment is witnessing the fastest growth, driven by the increasing trend of outsourcing production processes by biopharmaceutical companies looking to reduce costs and improve efficiency.

Bioprocess Technology Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Bioprocess Technology Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology.

Key Players

The "Global Bioprocess Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Lonza Group Ltd., Becton, Dickinson and Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Global Bioprocess Technology Market: Recent Developments
  • In August 2024 Merck KGaA announced a strategic partnership with Pfizer to enhance the bioprocessing capabilities for monoclonal antibody production. This collaboration aims to leverage Merck's advanced bioprocess technology platforms to improve efficiency and scalability in drug development.
  • In July 2024 Thermo Fisher Scientific opened a new bioprocessing facility in Massachusetts, aimed at expanding its production capacity for cell culture media and other bioprocessing solutions.
  • In June 2024 Sartorius completed the acquisition of a bioprocessing technology startup that specializes in cell culture systems. This acquisition aligns with Sartorius's strategy to strengthen its portfolio of innovative solutions for biopharmaceutical manufacturing.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.10 RESEARCH FLOW
  • 2.11 DATA SOURCES
  • 2.12 KEY INSIGHTS FROM INDUSTRY EXPERTS

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 GLOBAL BIOPROCESS TECHNOLOGY ECOLOGY MAPPING
  • 3.3 GLOBAL BIOPROCESS TECHNOLOGY MARKET ATTRACTIVENESS
  • 3.4 GLOBAL BIOPROCESS TECHNOLOGY ABSOLUTE MARKET OPPORTUNITY
  • 3.5 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICAL INSIGHTS
  • 3.6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE(USD MILLION)
  • 3.7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
  • 3.8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
  • 3.9 FUTURE MARKET OPPORTUNITIES
  • 3.10 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 RISE IN DISEASE BURDEN.
    • 4.2.2 ONGOING TREND OF OUTSOURCING OF BIOPROCESS DEVELOPMENT
  • 4.3 MARKET RESTRAINT
    • 4.3.1 HIGH CAPITAL INVESTMENT AND HIGH COST OF INSTRUMENTS
    • 4.3.2 STRINGENT GOVERNMENT REGULATIONS.
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISE IN RESEARCH AND DEVELOPMENT INVESTMENT FOR BIOTECHNOLOGY
    • 4.4.2 ROBUST BIOPHARMACEUTICAL PIPELINE
  • 4.5 IMPACT OF COVID19 ON THE GLOBAL MARKET
  • 4.6 PORTER'S FIVE FORCES ANALYSIS
    • 4.6.1 THREAT OF NEW ENTRANTS
    • 4.6.2 THREAT OF SUBSTITUTES
    • 4.6.3 BARGAINING POWER OF SUPPLIERS
    • 4.6.4 BARGAINING POWER OF BUYERS
    • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 4.7 MACROECONOMIC ANALYSIS
  • 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY PRODUCT

  • 5.1 OVERVIEW
  • 5.2 Bioprocess Instruments
  • 5.3 Bioprocess Services

6 MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 Pharmaceuticals
  • 6.3 Biotechnology
  • 6.4 Food and Beverage
  • 6.5 Environmental Management

7 MARKET, BY END-USER

  • 7.1 OVERVIEW
  • 7.2 Biopharmaceutical Companies
  • 7.3 Academic and Research Institutes
  • 7.4 Contract Manufacturing Organizations

8 MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
    • 8.2.2 U.S.
    • 8.2.3 CANADA
    • 8.2.4 MEXICO
  • 8.3 EUROPE
    • 8.3.1 EUROPE MARKET SNAPSHOT
    • 8.3.2 GERMANY
    • 8.3.3 U.K.
    • 8.3.4 FRANCE
    • 8.3.5 ITALY
    • 8.3.6 SPAIN
    • 8.3.7 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
    • 8.4.2 CHINA
    • 8.4.3 JAPAN
    • 8.4.4 INDIA
    • 8.4.5 REST OF APAC
  • 8.5 LATIN AMERICA
    • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
    • 8.5.2 BRAZIL
    • 8.5.3 ARGENTINA
    • 8.5.4 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST AND AFRICA
    • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
    • 8.6.2 UAE
    • 8.6.3 SAUDI ARABIA
    • 8.6.4 SOUTH AFRICA
    • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPETITIVE SCENARIO
  • 9.3 COMPANY MARKET RANKING ANALYSIS
  • 9.4 COMPANY REGIONAL FOOTPRINT
  • 9.5 COMPANY INDUSTRY FOOTPRINT
  • 9.6 ACE MATRIX
    • 9.6.1 ACTIVE
    • 9.6.2 CUTTING EDGE
    • 9.6.3 EMERGING
    • 9.6.4 INNOVATORS

10 COMPANY PROFILES

  • 10.1 GE HEALTHCARE COMPANY
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY INSIGHTS
    • 10.1.3 SEGMENT BREAKDOWN
    • 10.1.4 PRODUCT BENCHMARKING
    • 10.1.5 KEY DEVELOPMENTS
    • 10.1.6 SWOT ANALYSIS
    • 10.1.7 WINNING IMPERATIVES
    • 10.1.8 CURRENT FOCUS & STRATEGIES
    • 10.1.9 THREAT FROM COMPETITION
  • 10.2 THERMO FISHER SCIENTIFIC
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 COMPANY INSIGHTS
    • 10.2.1 SEGMENT BREAKDOWN
    • 10.2.2 PRODUCT BENCHMARKING
    • 10.2.3 KEY DEVELOPMENTS
    • 10.2.4 WINNING IMPERATIVES
    • 10.2.5 CURRENT FOCUS & STRATEGIES
    • 10.2.6 THREAT FROM COMPETITION
    • 10.2.7 SWOT ANALYSIS
  • 10.3 DANAHER CORPORATION
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 COMPANY INSIGHTS
    • 10.3.3 SEGMENT BREAKDOWN
    • 10.3.4 PRODUCT BENCHMARKING
    • 10.3.5 WINNING IMPERATIVES
    • 10.3.6 CURRENT FOCUS & STRATEGIES
    • 10.3.7 THREAT FROM COMPETITION
    • 10.3.8 SWOT ANALYSIS
  • 10.4 LCG GROUP
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 COMPANY INSIGHTS
    • 10.4.3 PRODUCT BENCHMARKING
  • 10.5 MERCK GROUP
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 COMPANY INSIGHTS
    • 10.5.3 SEGMENT BREAKDOWN
    • 10.5.4 PRODUCT BENCHMARKING
  • 10.6 LONZA GROUP AG
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 COMPANY INSIGHTS
    • 10.6.3 SEGMENT BREAKDOWN
    • 10.6.4 PRODUCT BENCHMARKING
  • 10.7 SARTORIUS AG.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 COMPANY INSIGHTS
    • 10.7.3 SEGMENT BREAKDOWN
    • 10.7.4 PRODUCT BENCHMARKING
  • 10.8 CORNING INCORPORATED
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 COMPANY INSIGHTS
    • 10.8.3 SEGMENT BREAKDOWN
    • 10.8.4 PRODUCT BENCHMARKING
  • 10.9 BIO-RAD LABORATORIES, INC.
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 COMPANY INSIGHTS
    • 10.9.3 SEGMENT BREAKDOWN
    • 10.9.4 PRODUCT BENCHMARKING

LIST OF TABLES

  • TABLE1 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
  • TABLE 2 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 3 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLES & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 4 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 5 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
  • TABLE 8 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRIES, 2022 - 2030 (USD MILLION)
  • TABLE 9 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE10 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE11 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE12 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE13 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE14 U.S. BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE15 U.S. BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE16 U.S. BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE17 U.S.BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE18 U.S.BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE19 CANADABIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 20 CANADA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 21 CANADA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 22 CANADA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 23 CANADA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 24 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 25 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 26 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 27 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 28 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 29 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 30 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 31 EUROPEBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 32 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 33 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 34 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 35 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 36 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 37 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 38 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 39 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 40 U.K BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 41 U.K BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 42 U.K BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 43 U.K BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 44 U.K BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 45 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 46 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 47 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 48 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 49 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 50 ITALY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 51 ITALY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 52 ITALY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 53 ITALY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 54 ITALY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 55 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 56 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 57 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 58 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 59 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 60 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 61 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 62 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 63 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 64 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 66 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 67 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 68 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 69 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 70 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 71 CHINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 72 CHINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 73 CHINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 74 CHINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 75 CHINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 76 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 77 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMAABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 78 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 79 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 80 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 81 INDIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 82 INDIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE A& ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 83 INDIA BIOPROCESS TECHNOLOGY MARKET, BY INTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 84 INDIABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 85 INDIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 86 REST OF ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 87 REST OF ASIA PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 88 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 89 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 90 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE 92 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 93 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 94 LATIN AMERICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE 95 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE 96 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE 97 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE 98 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE 99 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE100 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE101 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE102 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE103 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE104 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE105 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE106 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE107 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE108 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE109 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE110 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE111 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION
  • TABLE112 MIDDLE EAST AND AFRICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
  • TABLE113 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE114 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE115 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE116 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE117 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE118 UAE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE119 UAE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE120 UAE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE121 UAE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE122 UAE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE123 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE124 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE125 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE126 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE127 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
  • TABLE128 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE129 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE130 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE131 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE132 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE133 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
  • TABLE134 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
  • TABLE135 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
  • TABLE136 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
  • TABLE137 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
  • TABLE138 COMPANY MARKET RANKING ANALYSIS
  • TABLE139 COMPANY REGIONAL FOOTPRINT
  • TABLE140 COMPANY INDUSTRY FOOTPRINT
  • TABLE141 GE HEALTHCARE COMPANY: PRODUCT BENCHMARKING
  • TABLE142 GE HEALTHCARE: KEY DEVELOPMENTS
  • TABLE143 GE HEALTHCARE: WINNING IMPERATIVES
  • TABLE144 THERMO FISHER SCIENTIFIC: PRODUCT BENCHMARKING
  • TABLE145 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS
  • TABLE146 THERMO FISHER SCIENTIFIC: WINNING IMPERATIVES
  • TABLE147 DANAHER CORPORATION: PRODUCT BENCHMARKING
  • TABLE148 DANAHER CORPORATION: WINNING IMPERATIVES
  • TABLE149 LCG GROUP: PRODUCT BENCHMARKING
  • TABLE150 MERCK GROUP: PRODUCT BENCHMARKING
  • TABLE151 LONZA GROUP AG: PRODUCT BENCHMARKING
  • TABLE152 SARTORIUS AG: PRODUCT BENCHMARKING
  • TABLE153 CORNING INCORPORATED: PRODUCT BENCHMARKING
  • TABLE154 BIO-RAD LABORATORIES, INC.: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE1 GLOBAL BIOPROCESS TECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICALINSIGHTS, 2023-2030
  • FIGURE 8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BYTYPE(USD MILLION)
  • FIGURE 9 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
  • FIGURE10 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
  • FIGURE11 FUTURE MARKET OPPORTUNITIES
  • FIGURE12 NORTH AMERICA DOMINATED THE MARKET IN 2021
  • FIGURE13 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
  • FIGURE14 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE15 VALUE CHAIN ANALYSIS
  • FIGURE16 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE
  • FIGURE17 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION
  • FIGURE18 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER
  • FIGURE19 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
  • FIGURE 20 KEY STRATEGIC DEVELOPMENTS
  • FIGURE 21 ACE MATRIX
  • FIGURE 22 GE HEALTHCARE: COMPANY INSIGHT
  • FIGURE 23 GE HEALTHCARE COMPANY: BREAKDOWN
  • FIGURE 24 GE HEALTHCARE: SWOT ANALYSIS
  • FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY INSIGHT
  • FIGURE 26 THERMO FISHER SCIENTIFIC: BREAKDOWN
  • FIGURE 27 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
  • FIGURE 28 DANAHER CORPORATION: COMPANY INSIGHT
  • FIGURE 29 DANAHER CORPORATION: BREAKDOWN
  • FIGURE 30 DANAHER CORPORATION: SWOT ANALYSIS
  • FIGURE 31 LCG GROUP: COMPANY INSIGHT
  • FIGURE 32 MERCK GROUP: COMPANY INSIGHT
  • FIGURE 33 MERCK GROUP: BREAKDOWN
  • FIGURE 34 LONZA GROUP AG: COMPANY INSIGHT
  • FIGURE 35 LONZA GROUP AG: BREAKDOWN
  • FIGURE 36 SARTORIUS AG: COMPANY INSIGHT
  • FIGURE 37 SARTORIUS AG: BREAKDOWN
  • FIGURE 38 CORNING INCORPORATED: COMPANY INSIGHT
  • FIGURE 39 CORNING INCORPORATED: BREAKDOWN
  • FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY INSIGHT
  • FIGURE 41 CORNING INCORPORATED: BREAKDOWN